Drugs / MINNELIDE FREE SALT
MINNELIDE FREE SALT
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01927965 | Aug 2013 → Oct 2016 | — | Minneamrita Therapeutics LLC | Completed | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MINNELIDE FREE SALT | ChEMBL registry synonym — accepted as the source's own label CHEMBL3742465 ↗ |
| Known as | Minnelide | “Minnelide” NCT01927965 ↗ |
| Known as | Minnelide 001 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01927965 ↗ |
| Modality | Small molecule | — CHEMBL3742465 ↗ |
| Route | Intravenous | “Minnelide™ will be given as a single agent intravenously as a 30-minute infusion daily x 21 days followed by a 7-day rest period.” NCT01927965 ↗ |